Analysis of Optimal Treatment Sequencing of Surufatinib and Somatostatin Analogs in Neuroendocrine Tumors: A Retrospective Cohort Study
Clinical trial NCT07534371 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07534371
- Sponsor
- West China Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-03-06
- Primary completion
- 2026-07-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.